IL127701A0 - Hiv envelope polypeptides and vaccine - Google Patents

Hiv envelope polypeptides and vaccine

Info

Publication number
IL127701A0
IL127701A0 IL12770197A IL12770197A IL127701A0 IL 127701 A0 IL127701 A0 IL 127701A0 IL 12770197 A IL12770197 A IL 12770197A IL 12770197 A IL12770197 A IL 12770197A IL 127701 A0 IL127701 A0 IL 127701A0
Authority
IL
Israel
Prior art keywords
vaccine
hiv envelope
envelope polypeptides
polypeptides
hiv
Prior art date
Application number
IL12770197A
Other languages
English (en)
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of IL127701A0 publication Critical patent/IL127701A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IL12770197A 1996-07-08 1997-07-03 Hiv envelope polypeptides and vaccine IL127701A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US67673796A 1996-07-08 1996-07-08
PCT/US1997/009690 WO1998001564A1 (fr) 1996-07-08 1997-07-03 Polypeptides d'enveloppe du hiv et vaccin

Publications (1)

Publication Number Publication Date
IL127701A0 true IL127701A0 (en) 1999-10-28

Family

ID=24715764

Family Applications (2)

Application Number Title Priority Date Filing Date
IL12770197A IL127701A0 (en) 1996-07-08 1997-07-03 Hiv envelope polypeptides and vaccine
IL127701A IL127701A (en) 1996-07-08 1998-12-23 HIV gp 120 ENVELOPE POLYPEPTIDES, VACCINE AND METHODS FOR THEIR PREPARATION

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL127701A IL127701A (en) 1996-07-08 1998-12-23 HIV gp 120 ENVELOPE POLYPEPTIDES, VACCINE AND METHODS FOR THEIR PREPARATION

Country Status (13)

Country Link
US (1) US6090392A (fr)
EP (1) EP0942988A1 (fr)
JP (1) JP2000515368A (fr)
AP (1) AP1282A (fr)
AU (1) AU727107B2 (fr)
CA (1) CA2259965A1 (fr)
ID (1) ID17767A (fr)
IL (2) IL127701A0 (fr)
NZ (1) NZ333500A (fr)
OA (1) OA10954A (fr)
TW (1) TWI221846B (fr)
WO (1) WO1998001564A1 (fr)
ZA (1) ZA975889B (fr)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2903999A (en) * 1998-03-12 1999-09-27 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Methods and compositions of chemokine-tumor antigen fusion proteins as cancer vaccines
MXPA02007478A (es) 2000-02-04 2004-08-23 Univ Duke Vacuna contra el virus de inmunodeficiencia humana.
WO2001083535A2 (fr) * 2000-05-02 2001-11-08 Simon Fraser University Peptides pouvant etre utilises en tant que vaccin et/ou traitement contre l'infection par hiv
US20030228320A1 (en) * 2000-08-18 2003-12-11 Ashdown Martin Leonard Retroviral immunotherapy
AUPS065002A0 (en) 2002-02-20 2002-03-14 Immunaid Pty Ltd Strategy for retroviral immunotherapy
US7754676B2 (en) 2000-09-15 2010-07-13 The United States Of America As Represented By The Department Of Health And Human Services Defensin-antigen fusion proteins
US7897152B2 (en) 2000-09-18 2011-03-01 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Viral chemokine-antigen fusion proteins
US20060116325A1 (en) * 2001-02-15 2006-06-01 Oleg Chertov Methods and compositions for inhibiting hiv-coreceptor interactions
AUPS054702A0 (en) * 2002-02-14 2002-03-07 Immunaid Pty Ltd Cancer therapy
CA2505583C (fr) * 2002-12-03 2014-07-15 University Of Massachusetts Vaccins a adn polyvalents contre la glycoproteine du vih-1 primaire et procedes de vaccination
MXPA05013334A (es) * 2003-06-12 2006-05-19 Vexgen Inc Glucoproteinas de envoltura de vih-1 que tienen estructuras de disulfuro inusuales.
US8076060B2 (en) * 2003-08-04 2011-12-13 Emil William Chynn Vaccination and immunotherapy as new therapeutic modalities in the treatment of glaucoma
WO2005040816A1 (fr) 2003-10-24 2005-05-06 Immunaid Pty Ltd Methode therapeutique
JP5386083B2 (ja) * 2004-09-08 2014-01-15 イミューンネイド ピーティーワイ リミテッド 自己免疫疾患および変性疾患を治療する方法
WO2006031870A2 (fr) * 2004-09-14 2006-03-23 Argos Therapeutics, Inc. Amplification de souches independantes d'agents pathogenes et vaccins les comprenant
CN101313216A (zh) * 2005-09-22 2008-11-26 普洛茨股份有限公司 酵母突变体中产生的糖基化多肽及其使用方法
WO2009017743A2 (fr) * 2007-07-30 2009-02-05 Argos Therapeutics, Inc. Amorces et sondes améliorées pour l'amplification et la détection des polynucléotides gag, rev et nef du vih
KR101701198B1 (ko) 2008-06-19 2017-02-01 배리에이션 바이오테크놀로지스 아이엔씨. 인플루엔자를 치료하기 위한 조성물 및 방법
HUE026456T2 (en) 2009-05-27 2016-05-30 Biotempus Ltd Methods of treating diseases
EP2451950B9 (fr) 2009-07-06 2016-11-23 Variation Biotechnologies Inc. Procédés de préparation de vésicules et formulations obtenues à partir de celles-ci
WO2011005772A1 (fr) 2009-07-06 2011-01-13 Variation Biotechnologies, Inc. Procédés pour préparer des vésicules et formulations produites à partir de ces procédés
CA2793959C (fr) 2010-03-25 2019-06-04 Oregon Health & Science University Glycoproteines du cmv et vecteurs recombines
BR112013000394B8 (pt) 2010-07-06 2022-01-18 Variation Biotechnologies Inc Composição imunogênica, uso da mesma e método para preparar a referida composição
EP2663327A4 (fr) 2011-01-13 2015-12-02 Variation Biotechnologies Inc Compositions et méthodes de traitement d'infections virales
CA2832109C (fr) 2011-06-10 2021-07-06 Oregon Health & Science University Glycoproteines de cmv et vecteurs recombinants cmv
EP2568289A3 (fr) 2011-09-12 2013-04-03 International AIDS Vaccine Initiative Immunosélection du virus de la stomatite vésiculaire recombinant exprimant les protéines du VIH-1 par des anticorps largement neutralisants
US9402894B2 (en) 2011-10-27 2016-08-02 International Aids Vaccine Initiative Viral particles derived from an enveloped virus
US20140356399A1 (en) 2012-01-12 2014-12-04 Variation Biotechnologies, Inc. Compositions and methods for treating viral infections
EP4008354A1 (fr) 2012-01-27 2022-06-08 Variation Biotechnologies Inc. Procédés et compositions pour agents thérapeutiques
ES2631608T3 (es) 2012-06-27 2017-09-01 International Aids Vaccine Initiative Variante de la glicoproteína Env del VIH-1
EP2928924A4 (fr) 2012-12-04 2016-07-13 Univ Maryland Anticorps liant la protéine env du vih-1, protéines de fusion et leurs méthodes d'utilisation
US20150065381A1 (en) 2013-09-05 2015-03-05 International Aids Vaccine Initiative Methods of identifying novel hiv-1 immunogens
US10058604B2 (en) 2013-10-07 2018-08-28 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
US10174292B2 (en) 2015-03-20 2019-01-08 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
US9931394B2 (en) 2015-03-23 2018-04-03 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE138100T1 (de) * 1984-12-24 1996-06-15 Genentech Inc Fusionen von aids-verwandten polypeptiden
EP0279688B1 (fr) * 1987-02-20 1997-04-16 Genentech, Inc. Méthodes et compositions pour l'utilisation de polypeptides env et anticorps anti-env de HIV
IL89118A0 (en) * 1988-02-03 1989-08-15 Microgenesys Inc Vaccine containing polypeptides derived from the envelope gene of human immunodeficiency virus type 1
EP0339504A3 (fr) * 1988-04-26 1990-09-12 The Du Pont Merck Pharmaceutical Company Virus d'immunodéficience humaine (HIV) peptide env-codé capable de provoquer les anticorps inhibiteurs du HIV dans les mammifères
US5116740A (en) * 1988-08-16 1992-05-26 Akzo N.V. Method for producing native hiv gp160
EP0493508A1 (fr) * 1989-09-22 1992-07-08 Idec Pharmaceuticals Corporation Nouveaux peptides associes a la region de liaison cd4 de la gp120 et leur mode d'emploi
DK0527760T3 (da) * 1990-04-03 1995-11-27 Genentech Inc Fremgangsmåder og præparater til vaccination mod HIV
CA2078545A1 (fr) * 1990-04-03 1991-10-04 Timothy J. Gregory Polypeptides de l'enveloppe de vih
CA2164505A1 (fr) * 1993-06-07 1994-12-22 Phillip W. Berman Polypeptides de l'enveloppe du vih

Also Published As

Publication number Publication date
CA2259965A1 (fr) 1998-01-15
JP2000515368A (ja) 2000-11-21
OA10954A (en) 2001-10-25
US6090392A (en) 2000-07-18
NZ333500A (en) 2000-09-29
AU3567797A (en) 1998-02-02
TWI221846B (en) 2004-10-11
IL127701A (en) 2006-08-01
AU727107B2 (en) 2000-11-30
ID17767A (id) 1998-01-22
AP9901432A0 (en) 1999-03-31
ZA975889B (en) 1998-02-23
WO1998001564A1 (fr) 1998-01-15
AP1282A (en) 2004-06-09
EP0942988A1 (fr) 1999-09-22

Similar Documents

Publication Publication Date Title
AP9901432A0 (en) Hiv envelope polypeptides and vaccine
CZ20011341A3 (cs) Pomocné přípravky a vakciny
EP0708659A4 (fr) Polypeptides d'enveloppe du vih
PL332633A1 (en) Vaccines
HUP9700446A3 (en) Oilsuspension-concentrate and using thereof
HU9701314D0 (en) Translucent ceramic and initial arc tube
GB9705903D0 (en) VP22 Proteins and uses thereof
EP0885293A4 (fr) Polypeptides de chemokine humaine
HUP0100192A3 (en) Improved stomach-action molluscicides and preparation thereof
GB9626864D0 (en) Vaccine
GB2331521B (en) Vaccine preparations
IL124430A0 (en) An envelope and an envelope construction
GB2336844B (en) Anti-hiv peptides and proteins
GB9625968D0 (en) Vaccine
IL115197A0 (en) Vaccine preparations
EP0686569A3 (fr) Enveloppe ou similaire
GB9423663D0 (en) Viral preparations, immunogens, and vaccines
ZA973824B (en) Vaccines
AU6293896A (en) Sarcocystis vaccine
PL104759U1 (en) Correspondence envelope
GB9603322D0 (en) Viral preparations,immunogens and vaccines
GB9611334D0 (en) Viral antigens and their preparation
GB9703202D0 (en) HIV vaccine
PL104231U1 (en) Envelope
GB9620856D0 (en) Virus vaccine

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed